Buscar
Nanobiotix SA
NBTXAñadir a la lista de seguimiento
39.480USD
+1.780+4.72%
Cierre 07/01, 16:00（ET）Cotizaciones retrasadas 15 min
1.92BCap. mercado
PérdidaP/E TTM
Más Datos de Nanobiotix SA Compañía
Nanobiotix SA is a France-based nanomedicine company. The Company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. It develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The Company's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.
Información de Nanobiotix SA
Símbolo de cotizaciónNBTX
Nombre de la empresaNanobiotix SA
Fecha de salida a bolsaOct 29, 2012
Director ejecutivoLevy (Laurent)
Número de empleados108
Tipo de seguridadDepository Receipt
Fin del año fiscalOct 29
Dirección60 rue de Wattignies
CiudadPARIS
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísFrance
Código postal75012
Teléfono33140260470
Sitio Webhttps://www.nanobiotix.com
Símbolo de cotizaciónNBTX
Fecha de salida a bolsaOct 29, 2012
Director ejecutivoLevy (Laurent)
Ejecutivos de Nanobiotix SA
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Laurent Levy, Ph.D.
Dr. Laurent Levy, Ph.D.
Chief Executive Officer
Chief Executive Officer
--
--
Dr. Alain Herrera
Dr. Alain Herrera
Independent Director
Independent Director
--
--
Ms. Anne-Marie Graffin
Ms. Anne-Marie Graffin
Independent Vice Chairwoman of the of the Board
Independent Vice Chairwoman of the of the Board
--
--
Mr. Enno Spillner
Mr. Enno Spillner
Independent Director
Independent Director
--
--
Dr. Gary M. Phillips, M.D.
Dr. Gary M. Phillips, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Bart Van Rhijn
Mr. Bart Van Rhijn
Chief Financial & Business Officer
Chief Financial & Business Officer
--
--
Ms. Anne-Juliette Hermant
Ms. Anne-Juliette Hermant
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Dr. Louis Kayitalire, M.D.
Dr. Louis Kayitalire, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Craig West
Mr. Craig West
Senior Vice President - Investor Relations
Senior Vice President - Investor Relations
--
--
Ms. Anne-Sophie Lariviere
Ms. Anne-Sophie Lariviere
Vice President - Strategy & Operational Excellence
Vice President - Strategy & Operational Excellence
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Laurent Levy, Ph.D.
Dr. Laurent Levy, Ph.D.
Chief Executive Officer
Chief Executive Officer
--
--
Dr. Alain Herrera
Dr. Alain Herrera
Independent Director
Independent Director
--
--
Ms. Anne-Marie Graffin
Ms. Anne-Marie Graffin
Independent Vice Chairwoman of the of the Board
Independent Vice Chairwoman of the of the Board
--
--
Mr. Enno Spillner
Mr. Enno Spillner
Independent Director
Independent Director
--
--
Dr. Gary M. Phillips, M.D.
Dr. Gary M. Phillips, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Bart Van Rhijn
Mr. Bart Van Rhijn
Chief Financial & Business Officer
Chief Financial & Business Officer
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Nanobiotix SA?
Los cinco principales accionistas de Nanobiotix SA son: Dr. Laurent Levy, Ph.D.
¿Cuántas instituciones poseen acciones de Nanobiotix SA (NBTX)?
A fecha de 2026Q1, 30 instituciones poseen acciones de Nanobiotix SA, con un valor de mercado combinado de aproximadamente 5.71M, lo que representa el 11.79% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -3044728.00.